Genome Biology

official impact factor 6.89

Open Access Highly Access

Breaking the waves: improved detection of copy number variation from microarray-based comparative genomic hybridization

John C Marioni, Natalie P Thorne, Armand Valsesia, Tomas Fitzgerald, Richard Redon, Heike Fiegler, T Daniel Andrews, Barbara E Stranger, Andrew G Lynch, Emmanouil T Dermitzakis, Nigel P Carter, Simon Tavaré and Matthew E Hurles*

Genome Biology 2007, 8:R228 doi:10.1186/gb-2007-8-10-r228

Accesses  

  • Last 30 days: 117 accesses
  • Last year: 1220 accesses
  • All time: 9663 accesses

Cited by

BioMed Central: 4 citations

Research article   Open Access Highly Accessed

Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform

Jeanette E Eckel-Passow, Elizabeth J Atkinson, Sooraj Maharjan, Sharon LR Kardia, Mariza de Andrade BMC Bioinformatics 2011, 12:220 (31 May 2011)

Method   Open Access Highly Accessed

A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data

Christopher Yau, Dmitri Mouradov, Robert N Jorissen, Stefano Colella, Ghazala Mirza, Graham Steers, Adrian Harris, Jiannis Ragoussis, Oliver Sieber, Christopher C Holmes Genome Biology 2010, 11:R92 (21 September 2010)

OncoSNP is a method for detecting CNVs in tumors from SNP array data that can account for contaminating healthy tissue.

Research article   Open Access Highly Accessed

The pitfalls of platform comparison: DNA copy number array technologies assessed

Christina Curtis, Andy G Lynch, Mark J Dunning, Inmaculada Spiteri, John C Marioni, James Hadfield, Suet-Feung Chin, James D Brenton, Simon Tavaré, Carlos Caldas BMC Genomics 2009, 10:588 (8 December 2009)

Research   Open Access

High resolution discovery and confirmation of copy number variants in 90 Yoruba Nigerians

Hajime Matsuzaki, Pei-Hua Wang, Jing Hu, Rich Rava, Glenn K Fu Genome Biology 2009, 10:R125 (9 November 2009)

Most microRNAs have a stronger inhibitory effect in estrogen receptor-negative than in estrogen receptor-positive breast cancers.